A Phase 2 Study to Evaluate Immune Responses of FluMist®

Status Completed

Clinical Trial Summary

The primary objective of this study is to describe the level of serum antibody and cellular immune responses conferred by FluMist and TIV against influenza virus strains.

Clinical Trial Description

The primary objective of this study is to describe the level of serum antibody and cellular immune responses conferred by FluMist and TIV against antigenically matched and antigenically mismatched influenza virus strains. The secondary objective of this study is to describe the safety of FluMist and TIV in subjects 12 to <36 months of age. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00461981
Study type	Interventional
Source	MedImmune LLC
Contact
Status	Completed
Phase	Phase 2
Start date	May 2007
Completion date	February 2008

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03285997` - A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age	Phase 3
Recruiting	`NCT05996549` - Cost-effectiveness of the Influenza Vaccination	Phase 4
Completed	`NCT04546854` - Influenza 2020/2021	N/A
Completed	`NCT05157425` - Effect of a Multi-strain Probiotic Formulation on Immune Response to Influenza Vaccination	N/A
Completed	`NCT01687517` - Efficacy and Safety of Influenza Vaccine During Sarcoidosis	Phase 3
Completed	`NCT01180699` - Intradermal Versus Intramuscular Trivalent Influenza Vaccine in Adult Solid Organ Transplant Recipients	N/A
Completed	`NCT00760175` - Intradermal Versus Intramuscular Trivalent Influenza Vaccine in Adult Lung Transplant Recipients	N/A
Completed	`NCT00542776` - Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine	N/A
Completed	`NCT06304038` - Cost-consequence Analysis of Influenza Vaccination in a Teaching Hospital in Rome
Recruiting	`NCT04086628` - Influenza Vaccine in Children With Asthma
Completed	`NCT02960815` - Imiquimod and Influenza Vaccine for Immunocompromised Patients	Phase 2
Completed	`NCT00828555` - Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting	N/A
Completed	`NCT04230343` - Limits of the Social Benefit Motive Among High-risk Patients: a Field Experiment on Influenza Vaccination Behaviour	N/A
Recruiting	`NCT03399357` - Evaluation of Metabolic Predictors of Influenza Vaccine Immune Response in the Singapore Elderly Population - the DYNAMIC Trial	N/A
Completed	`NCT02153671` - Immunogenicity of H5N1 Vaccine Following H5N2	Phase 2
Recruiting	`NCT05070494` - Efficacy of Different Doses of Influenza Vaccine in Chronic Hemodialysis Patients	Phase 4
Completed	`NCT04785794` - Safety and Immunogenicity of the Sing2016 M2SR H3N2 Monovalent Influenza Vaccine in Adults Ages 50 to 85 Years Old	Phase 1
Completed	`NCT05163847` - Safety and Immunogenicity of Cam2020 M2SR H3N2 Monovalent Influenza Vaccine Alone or With Licensed IIV in Older Adults	Phase 1
Not yet recruiting	`NCT04355806` - Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors
Completed	`NCT01368796` - Comparison of 4 Influenza Vaccines in Seniors	Phase 4